benzoyl peroxide: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Mayne Pharma	EPSOLAY	benzoyl peroxide	CREAM;TOPICAL	214510	NDA	Galderma Laboratories, L.P.	0299-5890-00	3 g in 1 BOTTLE, PUMP (0299-5890-00)	2022-05-09
Mayne Pharma	EPSOLAY	benzoyl peroxide	CREAM;TOPICAL	214510	NDA	Galderma Laboratories, L.P.	0299-5890-30	1 BOTTLE, PUMP in 1 BOX (0299-5890-30) / 30 g in 1 BOTTLE, PUMP	2022-05-09
Mayne Pharma	EPSOLAY	benzoyl peroxide	CREAM;TOPICAL	214510	NDA	Mayne Pharma Commercial LLC	51862-772-30	1 BOTTLE, PUMP in 1 CARTON (51862-772-30) / 30 g in 1 BOTTLE, PUMP	2025-08-01
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: February 19, 2026

This report analyzes the global supply chain for benzoyl peroxide (BPO) as a pharmaceutical active pharmaceutical ingredient (API) and excipient. Key manufacturers, regulatory considerations, and market dynamics impacting BPO supply for pharmaceutical applications are detailed. The analysis focuses on raw material sourcing, manufacturing processes, quality control, and global distribution networks.

What are the primary uses of Benzoyl Peroxide in pharmaceuticals?

Benzoyl peroxide is utilized in pharmaceuticals primarily as an active ingredient in topical treatments for acne vulgaris. Its antimicrobial and keratolytic properties make it effective in reducing Cutibacterium acnes bacteria and promoting the shedding of dead skin cells. BPO is also employed as a benzoylating agent in the synthesis of certain APIs. In some formulations, it can act as an excipient, though this is less common.

Who are the key manufacturers of pharmaceutical-grade Benzoyl Peroxide?

The global supply of pharmaceutical-grade benzoyl peroxide is concentrated among a limited number of specialized chemical manufacturers. These companies adhere to stringent Good Manufacturing Practices (GMP) to ensure API quality and consistency.

Key manufacturers include:

Acme Hardesty Co. (USA) - While known for a broad range of chemical distribution, Acme Hardesty supplies BPO for various industrial and pharmaceutical applications. Their BPO products meet USP/NF and EP specifications.
Jiangsu Sanjili Chemical Co., Ltd. (China) - A significant producer of organic peroxides, including BPO. They cater to both industrial and pharmaceutical sectors, with production capacity supporting global demand. Their BPO is often manufactured to meet pharmacopoeial standards.
Loba Chemie Pvt. Ltd. (India) - Loba Chemie manufactures and supplies a range of laboratory and pharmaceutical chemicals. Their BPO offerings are typically for research and development or smaller-scale pharmaceutical manufacturing.
Apollo Scientific Ltd. (UK) - Specializes in research chemicals and intermediates. Apollo Scientific supplies BPO for R&D purposes, with options for higher purity grades suitable for early-stage pharmaceutical development.
Sigma-Aldrich (Merck KGaA) (Global) - A major supplier of laboratory chemicals, reagents, and pharmaceutical ingredients. Sigma-Aldrich offers various grades of BPO, including those meeting USP and EP standards for pharmaceutical use.

These manufacturers operate global distribution networks, supplying BPO to pharmaceutical companies worldwide. Sourcing often involves direct procurement or through authorized distributors.

What are the regulatory requirements for Benzoyl Peroxide in pharmaceutical applications?

Pharmaceutical-grade benzoyl peroxide must comply with stringent regulatory standards to ensure safety and efficacy. These requirements vary by region but generally focus on purity, impurity profiles, manufacturing processes, and quality control.

Pharmacopoeial Standards

Benzoyl peroxide used in pharmaceuticals must meet the specifications outlined in major pharmacopoeias:

United States Pharmacopeia (USP) / National Formulary (NF): The USP monograph for Benzoyl Peroxide details tests for identity, assay, impurities (including benzoic acid, p-chlorobenzoic acid, and moisture), and physical characteristics. The assay for BPO is typically not less than 96.0% and not more than 104.0% of C14H10O2, calculated on the dried basis.
European Pharmacopoeia (EP): The EP monograph also defines strict purity criteria, including limits for related substances and residual solvents. Similar to the USP, it specifies assay requirements and testing for impurities.
Japanese Pharmacopoeia (JP): The JP sets forth its own standards for BPO quality, ensuring its suitability for pharmaceutical use within Japan.

Good Manufacturing Practices (GMP)

Manufacturers of pharmaceutical-grade BPO are required to operate under GMP guidelines established by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). GMP compliance ensures:

Quality Management Systems: Robust systems for product quality assurance and control.
Process Validation: Manufacturing processes are validated to consistently produce BPO meeting predetermined specifications.
Documentation: Comprehensive records of all manufacturing activities, quality control testing, and distribution.
Change Control: Formal procedures for managing any changes to manufacturing processes or materials.
Facility and Equipment Qualification: Ensuring manufacturing facilities and equipment are suitable for producing pharmaceutical ingredients.

Impurity Profiling

Detailed impurity profiling is critical. Regulatory agencies require manufacturers to identify and quantify potential impurities, including:

Benzoic Acid: A common impurity resulting from the decomposition of BPO.
4-Chlorobenzoyl Peroxide: A significant impurity if chlorinated starting materials are used or contamination occurs. The USP monograph has specific limits for this impurity.
Moisture Content: BPO can be sensitive to moisture, impacting its stability and efficacy.
Related Peroxides: Other organic peroxides that may arise during synthesis or storage.

The presence and levels of these impurities are closely monitored through validated analytical methods such as High-Performance Liquid Chromatography (HPLC).

Drug Master Files (DMFs)

Manufacturers often file Drug Master Files (DMFs) with regulatory agencies like the FDA. A DMF contains confidential, detailed information about the manufacturing, processing, packaging, and storage of a pharmaceutical ingredient. Pharmaceutical companies reference these DMFs in their New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs), allowing regulators to review the API's manufacturing without disclosing proprietary information to the drug product manufacturer.

What are the raw materials and manufacturing processes for Benzoyl Peroxide?

The synthesis of benzoyl peroxide involves specific raw materials and controlled chemical reactions. The purity of these starting materials directly influences the quality of the final BPO product.

Key Raw Materials

Benzoyl Chloride (C7H5ClO): This is a primary precursor. It is synthesized from benzoic acid and chlorinating agents like thionyl chloride (SOCl2) or phosphorus pentachloride (PCl5).
Sodium Peroxide (Na2O2) or Hydrogen Peroxide (H2O2): These are the oxidizing agents used to convert benzoyl chloride into benzoyl peroxide.
Sodium Hydroxide (NaOH) or Sodium Carbonate (Na2CO3): Used as a base to neutralize acidic byproducts and facilitate the reaction.
Solvents: Various solvents, such as water, toluene, or organic esters, are used during different stages of the reaction and purification process. The choice of solvent is critical for reaction efficiency and product isolation.

Manufacturing Processes

The most common industrial synthesis of benzoyl peroxide involves the reaction of benzoyl chloride with an alkali metal peroxide (typically sodium peroxide) or hydrogen peroxide in the presence of a base.

1. Reaction using Sodium Peroxide:

Benzoyl chloride reacts with sodium peroxide in an aqueous or biphasic (water/organic solvent) system. The reaction is typically carried out at controlled low temperatures (e.g., 0-10°C) to prevent decomposition of the peroxide.

$2\text{C}_7\text{H}_5\text{ClO} + \text{Na}_2\text{O}_2 \rightarrow (\text{C}_7\text{H}_5\text{CO})_2\text{O}_2 + 2\text{NaCl}$

A base like sodium hydroxide is often added to maintain an alkaline pH, which is favorable for the reaction and helps in the hydrolysis of any unreacted benzoyl chloride to benzoic acid.

2. Reaction using Hydrogen Peroxide:

Alternatively, benzoyl chloride can be reacted with hydrogen peroxide in the presence of a base. This method might involve using a phase-transfer catalyst to improve the reaction rate and yield.

$2\text{C}_7\text{H}_5\text{ClO} + \text{H}_2\text{O}_2 + 2\text{NaOH} \rightarrow (\text{C}_7\text{H}_5\text{CO})_2\text{O}_2 + 2\text{NaCl} + 2\text{H}_2\text{O}$

This reaction also requires careful temperature control.

Purification and Isolation:

Following the reaction, the crude benzoyl peroxide is isolated and purified. Common steps include:

Filtration: To separate the solid BPO from the reaction mixture.
Washing: The solid is washed with water to remove soluble salts (e.g., NaCl) and residual reactants.
Recrystallization: BPO is often recrystallized from suitable solvents (e.g., ethanol, acetic acid, or mixtures) to achieve the required pharmaceutical purity and crystal form.
Drying: The purified BPO is dried under vacuum at controlled temperatures to remove residual solvents and moisture. Care must be taken to avoid thermal decomposition.

The manufacturing process must be designed to minimize the formation of impurities such as benzoic acid and 4-chlorobenzoyl peroxide. Strict process controls, including temperature, pH, and reaction time, are essential. The final product is then subjected to rigorous quality control testing.

What are the market dynamics and supply chain challenges for Benzoyl Peroxide?

The market for pharmaceutical-grade benzoyl peroxide is influenced by several factors, including demand for acne treatments, regulatory compliance, and global supply chain resilience.

Demand Drivers

Acne Treatment Market: The primary driver for pharmaceutical BPO is its widespread use in over-the-counter (OTC) and prescription topical acne medications. The prevalence of acne globally, particularly among adolescents and young adults, sustains consistent demand.
Generic Drug Manufacturing: The availability of generic acne treatments that utilize BPO contributes to stable, high-volume demand from generic drug manufacturers.
Emerging Markets: Increasing access to healthcare and dermatological treatments in developing economies can lead to expanded demand for BPO-containing products.

Supply Chain Challenges

Raw Material Availability and Cost: Fluctuations in the price and availability of key raw materials like benzoyl chloride can impact BPO production costs and lead times. Geopolitical factors, trade policies, and the availability of upstream chemicals can create volatility.
Regulatory Scrutiny: Increasing regulatory expectations regarding impurity limits and GMP compliance can add complexity and cost to BPO manufacturing. Manufacturers must continually invest in process improvements and analytical capabilities.
Safety Concerns: Benzoyl peroxide is an organic peroxide, which can pose safety risks if not handled and stored properly. This requires specialized manufacturing facilities, strict safety protocols, and controlled transportation, adding to operational costs.
Geographic Concentration of Manufacturing: While demand is global, manufacturing is concentrated in specific regions. Disruptions in these regions (e.g., natural disasters, public health crises, geopolitical instability) can have a significant impact on global supply. For instance, any disruption to production in China or India, major hubs for chemical manufacturing, could lead to global shortages.
Quality Control and Assurance: Ensuring lot-to-lot consistency and meeting stringent pharmacopoeial standards requires robust quality control systems. Any deviation can lead to rejected batches, impacting supply availability and increasing costs for manufacturers.
Lead Times: The production cycle for specialized chemicals like BPO can involve significant lead times, from raw material procurement to final product delivery. This requires careful inventory management and forecasting by pharmaceutical companies.
Competition and Pricing: While the market is not overly saturated, competition among a few key GMP-compliant manufacturers influences pricing. However, the specialized nature of pharmaceutical-grade production and regulatory hurdles limit new entrants.

Market Trends

Consolidation: The chemical industry has seen consolidation, which can affect the number of available suppliers. Pharmaceutical companies need to ensure their chosen suppliers have robust business continuity plans.
Sustainability: Increasing focus on sustainable manufacturing practices may influence the choice of solvents and production methods, potentially leading to process innovations.
Reshoring/Nearshoring: Global supply chain disruptions have prompted some pharmaceutical companies to re-evaluate their sourcing strategies, exploring options for more localized or regionalized supply chains for critical APIs and excipients, though this is complex for specialized chemicals like BPO.

The overall market for pharmaceutical BPO is mature, driven by established therapeutic uses. However, maintaining a stable supply requires careful management of regulatory compliance, raw material sourcing, and supply chain risk mitigation.

Key Takeaways

Pharmaceutical-grade benzoyl peroxide is primarily used in topical acne treatments.
Key global suppliers are specialized chemical manufacturers adhering to GMP, including Acme Hardesty, Jiangsu Sanjili Chemical, Loba Chemie, Apollo Scientific, and Sigma-Aldrich.
BPO must meet stringent USP, EP, and JP pharmacopoeial standards, with strict controls on purity and impurities like benzoic acid and 4-chlorobenzoyl peroxide.
Manufacturing involves the reaction of benzoyl chloride with sodium peroxide or hydrogen peroxide, followed by rigorous purification.
Market dynamics are driven by acne treatment demand, but supply chain challenges include raw material volatility, regulatory complexity, safety considerations, and geographic concentration of production.

Frequently Asked Questions

What is the typical shelf life of pharmaceutical-grade Benzoyl Peroxide? The shelf life of pharmaceutical-grade benzoyl peroxide is generally around 2 to 3 years when stored under recommended conditions (cool, dry, and protected from light). Manufacturers provide specific expiration dating based on stability studies.
Can Benzoyl Peroxide be used in oral or injectable pharmaceuticals? Benzoyl peroxide is not typically used in oral or injectable pharmaceutical formulations due to its reactivity, potential for decomposition, and irritant properties. Its primary application remains topical.
What analytical methods are used to test Benzoyl Peroxide purity? Purity is assessed using High-Performance Liquid Chromatography (HPLC) for assay and impurity profiling, titration for specific functional groups, Karl Fischer titration for moisture content, and spectroscopic methods for identification.
How does the form of Benzoyl Peroxide (e.g., powder, paste) affect its pharmaceutical application? The physical form is critical for formulation. Pharmaceutical BPO is typically supplied as a white crystalline powder. This powder is then formulated into creams, gels, lotions, or washes, with particle size and dispersibility being key formulation considerations.
Are there alternative active ingredients for acne treatment that compete with Benzoyl Peroxide? Yes, alternative active ingredients for acne treatment include salicylic acid, retinoids (e.g., tretinoin, adapalene), azelaic acid, and antibiotics (e.g., clindamycin). These alternatives offer different mechanisms of action and efficacy profiles.

Citations

[1] United States Pharmacopeial Convention. (2023). United States Pharmacopeia and National Formulary (USP 46 - NF 41). United States Pharmacopeial Convention.

[2] European Directorate for the Quality of Medicines & HealthCare. (2023). European Pharmacopoeia (Ph. Eur. 11th Edition). European Directorate for the Quality of Medicines & HealthCare.

[3] Japanese Pharmacopoeial Society. (2021). Japanese Pharmacopoeia (JP 18). Japanese Pharmacopoeial Society.

[4] FDA U.S. Food and Drug Administration. (2022). Guidance for Industry: ANDAs to Generic Drugs. U.S. Food and Drug Administration.

[5] EMA European Medicines Agency. (2012). Guideline on the Details of the Scientific Documentation Required for a Manufacturing Change for a Registered Active Substance. European Medicines Agency.

Suppliers and packagers for generic pharmaceutical drug: benzoyl peroxide